Regional gray matter changes and age predict individual treatment response in Parkinson's disease

We aimed at testing the potential of biomarkers in predicting individual patient response to dopaminergic therapy for Parkinson's disease. Treatment efficacy was assessed in 30 Parkinson's disease patients as motor symptoms improvement from unmedicated to medicated state as assessed by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballarini, Tommaso, Mueller, Karsten, Albrecht, Franziska, Růžička, Filip, Bezdicek, Ondrej, Růžička, Evžen, Roth, Jan, Vymazal, Josef, Jech, Robert, Schroeter, Matthias L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413309/
https://www.ncbi.nlm.nih.gov/pubmed/30558868
http://dx.doi.org/10.1016/j.nicl.2018.101636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413309/
https://www.ncbi.nlm.nih.gov/pubmed/30558868
http://dx.doi.org/10.1016/j.nicl.2018.101636

Ejemplares similares